Cover Image

A Prediction Model Based on Systemic Immune-Inflammatory Index Combined with Other Predictors for Major Adverse Cardiovascular Events in Acute Myocardial Infarction Patients

Xiaobo Li,1,2 Chen Yu,1 Xuewei Liu,3 Yejia Chen,1 Yutian Wang,1 Hongbin Liang,1 ShiFeng Qiu,1 Li Lei,1 Jiancheng Xiu1 1Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China; 2Department of Cardiology, Xiangdong Hospital, Hunan...

Full description

Saved in:

Bibliographic Details
Main Authors:	Li X (Author), Yu C (Author), Liu X (Author), Chen Y (Author), Wang Y (Author), Liang H (Author), Qiu S (Author), Lei L (Author), Xiu J (Author)
Format:	Book
Published:	Dove Medical Press, 2024-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SYNTAX score as predictor of adverse events in patients after acute myocardial infarction
by: Davidović Aleksandar, et al.
Published: (2021)

Growth Differentiation Factor-15 (GDF-15) as a Predictor of Major Adverse Cardiac Event in Acute Myocardial Infarction Patients
by: Annisa Tridamayanti, et al.
Published: (2022)

On-admission High Neutrophil to Lymphocyte Ratio as Predictor of In-hospital Adverse Cardiac Event in ST-elevation Myocardial Infarction
by: Anggoro B Hartopo1, et al.
Published: (2015)

Impact of Paroxysmal Atrial Tachycardia on Thromboembolic Events and Major Adverse Cardiovascular Events: A Single-Center Retrospective Study
by: Liu P, et al.
Published: (2024)

Association of Systemic Inflammatory Response Index and Pan-Immune-Inflammation-Value with Long-Term Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention
by: Liu Y, et al.
Published: (2023)

Significance of Multiple Lymphocyte-to-C-Reactive Protein Ratios in Predicting Long-Term Major Cardiovascular Adverse Events in Emergency Percutaneous Coronary Intervention Patients with ST-Segment Elevation Myocardial Infarction
by: Ye J, et al.
Published: (2024)

A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction
by: Enfa Zhao, et al.
Published: (2020)

Addition of Plasma Myeloperoxidase and Trimethylamine N-Oxide to the GRACE Score Improves Prediction of Near-Term Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction
by: Yu Tan, et al.
Published: (2021)

Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention
by: Defeng Pan, et al.
Published: (2021)

Major Risk Factors For Myocardial Infarction
by: Ahmed Abbas Kadhim
Published: (2013)

Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting
by: Zhe Liang, et al.
Published: (2021)

TIMI frame count as a predictor of major adverse cardiovascular events during the first month after primary PCI
by: kamyar Amin, et al.
Published: (2024)

Pulse pressure and inferior wall ST‑segment elevation myocardial infarction: investigating mortality, hospital major cardiovascular events, and long‑term prognosis
by: Enayatollah Enayatollah Hashemi-Jokandan, et al.
Published: (2023)

Predictors of recurrent cardiovascular events in patients with a single-vessel coronary artery disease after ST-segment elevation myocardial infarction
by: V. E. Oleynikov, et al.
Published: (2023)

Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer
by: Lei H, et al.
Published: (2021)

Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database
by: Hui Zhao, et al.
Published: (2023)

Identifying Immune Cell Infiltration and Hub Genes During the Myocardial Remodeling Process After Myocardial Infarction
by: Tian Y, et al.
Published: (2023)

Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease
by: Justin T. Morrison MD, et al.
Published: (2022)

Paeoniflorin improves cardiac function and decreases adverse postinfarction left ventricular remodeling in a rat model of acute myocardial infarction
by: Chen H, et al.
Published: (2018)

Identification of Immune-Related Genes in Patients with Acute Myocardial Infarction Using Machine Learning Methods
by: Zhu X, et al.
Published: (2022)

A simple angiographic index to predict adverse clinical outcome associated with acute myocardial infarction
by: Mustafa Tarık Ağaç, et al.
Published: (2014)

Subclinical Hypothyroidism Predicted Adverse Cardiovascular Events in Patients with Ejection Fraction Preserved Heart Failure
by: Tan Q, et al.
Published: (2024)

Paeoniflorin Improves Cardiac Function and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Rat Model of Acute Myocardial Infarction [Corrigendum]
by: Chen H, et al.
Published: (2020)

Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney Disease
by: Bojan Stopic, et al.
Published: (2022)

Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case-Control Study
by: Nawal Farhat, et al.
Published: (2020)

Heart Rate Variability Predicts Major Adverse Cardiovascular Events and Hospitalization in Maintenance Hemodialysis Patients
by: Jiun-Chi Huang, et al.
Published: (2017)

Association between late sleeping and major adverse cardiovascular events in patients with percutaneous coronary intervention
by: Xiao-Qing Lian, et al.
Published: (2024)

Major adverse cardiovascular events: analysis of diabetics with coronary syndrome on prior use of acetylsalicylic acid
by: Edna Rodrigues de Melo, et al.
Published: (2022)

Correlation between changes in serum levels of GDF11 and Cdc42 and major adverse cardiovascular events in maintenance hemodialysis elders
by: Qiang Lei, et al.
Published: (2024)

Acute myocardial infarction-like event in a young patient with biventricular arrhythmogenic cardiomyopathy
by: Y. V. Stavtseva, et al.
Published: (2024)

ACE Gene Mutations (rs577350502) in Early-Onset and Recurrent Myocardial Infarction: A Case Report and Review
by: Deng X, et al.
Published: (2024)

Monomeric CRP Aggravates Myocardial Injury After Myocardial Infarction by Polarizing the Macrophage to Pro-Inflammatory Phenotype Through JNK Signaling Pathway
by: Zha Z, et al.
Published: (2021)

The effects of socioeconomic status on major adverse cardiovascular events: a nationwide population-based cohort study
by: Eun Hui Bae, et al.
Published: (2023)

New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins
by: Jah Yeon Choi, et al.
Published: (2021)

Predictors of acute myocardial infarction and/or acute complication in unstable angina
by: Kerdphoom Minaphinant
Published: (2014)

Predictors of Quality of Life in Patients With Myocardial Infarction Combined With Dyslipidemia
by: Mengran Zhang, et al.
Published: (2021)

Predictors and etiology of in-hospital mortality in patients with acute myocardial infarction
by: T. H. Hoang, et al.
Published: (2024)

PREDICTORS OF LONG-TERM PROGNOSIS OF MYOCARDIAL INFARCTION: FOCUS ON THE PHARMACOKINETICS
by: M. V. Solodun, et al.
Published: (2016)

Antidepressant Use and the Risk of Major Adverse Cardiovascular Events in Patients Without Known Cardiovascular Disease: A Retrospective Cohort Study
by: Ha Young Jang, et al.
Published: (2020)

A Nomogram for Predicting In-Hospital Major Adverse Cardio- and Cerebro-Vascular Events in Patients Undergoing Major Noncardiac Surgery: A Large-Scale Nested Case-Control Study
by: Wu X, et al.
Published: (2022)